[go: up one dir, main page]

PE20011333A1 - Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2 - Google Patents

Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2

Info

Publication number
PE20011333A1
PE20011333A1 PE2001000241A PE2001000241A PE20011333A1 PE 20011333 A1 PE20011333 A1 PE 20011333A1 PE 2001000241 A PE2001000241 A PE 2001000241A PE 2001000241 A PE2001000241 A PE 2001000241A PE 20011333 A1 PE20011333 A1 PE 20011333A1
Authority
PE
Peru
Prior art keywords
alkyl
ona
derivatives
cyclooxygenase
metansulphonylphenyl
Prior art date
Application number
PE2001000241A
Other languages
English (en)
Inventor
Crespo Maria Isabel Crespo
Julia Josep Lluis Matallan
Mayorga Juan Miguel Jimenez
Gras Joan Feixas
Original Assignee
Almirall Prodesfarma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Ag filed Critical Almirall Prodesfarma Ag
Publication of PE20011333A1 publication Critical patent/PE20011333A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A DERIVADOS DE 2-FENILPIRAN-4-ONA DE FORMULA I, DONDE R1 ES ALQUILO, NR5R6; R5 Y R6 SON H, ALQUILO; R2 ES ALQUILO C3-C7, CICLOALQUILO, PIRIDILO, TIENILO, NAFTILO, TETRAHIDRONAFTILO, INDANILO, ENTRE OTROS; R3 ES ALQUILO, HIDROXIMETILO, ALCOXIMETILO, ALQUENILOXIMETILO C3-C7, ENTR OTROS; R4 ES H, ALQUILO, ALQUENILO, ALQUINILO, HALOGENO; X ES ENLACE, O, S, METILENO. SON COMPUESTOS PREFERIDOS 3-(2,4-DIFLUOROFENOXI)-6-ETIL-2-(4-METANSULFONILFENIL)-5-METIL-PIRAN-4-ONA; 3-CLORO-5-(2,4-DIFLUOROFENOXI)-6-(4-METANSULFONILFENIL)-2-METIL-PIRAN-4-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I INHIBE A CICLOOXIGENASA 2 Y PUEDE SER UTIL PARA EL TRATAMIENTO DEL DOLOR, FIEBRE, INFLAMACION MEDIANTE INHIBICION DE PROSTANOIDES QUE INDUCEN CONTRACCION DEL MUSCULO LISO O PARA TRATAR CANCER COLORECTAL, ENFERMEDADES NEURODEGENERATIVAS
PE2001000241A 2000-03-16 2001-03-13 Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2 PE20011333A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000637 2000-03-16

Publications (1)

Publication Number Publication Date
PE20011333A1 true PE20011333A1 (es) 2002-01-16

Family

ID=8492732

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000241A PE20011333A1 (es) 2000-03-16 2001-03-13 Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2

Country Status (27)

Country Link
US (1) US7354936B2 (es)
EP (1) EP1263751B1 (es)
JP (1) JP2003527389A (es)
KR (1) KR20030005221A (es)
CN (1) CN1429221A (es)
AR (1) AR030410A1 (es)
AT (1) ATE269316T1 (es)
AU (1) AU2001254692A1 (es)
BG (1) BG107101A (es)
BR (1) BR0109252A (es)
CA (1) CA2403149A1 (es)
CZ (1) CZ20023058A3 (es)
DE (1) DE60103859T2 (es)
EE (1) EE200200528A (es)
ES (1) ES2223830T3 (es)
HK (1) HK1048117A1 (es)
HU (1) HUP0301696A2 (es)
IL (1) IL151598A0 (es)
MX (1) MXPA02009016A (es)
NO (1) NO20024393L (es)
NZ (1) NZ521187A (es)
PE (1) PE20011333A1 (es)
PL (1) PL358062A1 (es)
RU (1) RU2002127728A (es)
SK (1) SK12832002A3 (es)
WO (1) WO2001068633A1 (es)
ZA (1) ZA200207184B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465509B2 (en) 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2
ES2213485B1 (es) * 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
CN102731456B (zh) * 2011-04-01 2014-07-09 华中科技大学 一种抗肿瘤化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH524614A (de) * 1969-12-31 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolderivaten
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
US4304728A (en) * 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
IL59748A (en) 1979-04-05 1983-11-30 Lilly Industries Ltd 5-substituted pyranone derivatives,their production and pharmaceutical compositions containing them
US6048850A (en) * 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
JPH09505295A (ja) * 1993-11-19 1997-05-27 パーク・デイビス・アンド・カンパニー プロテアーゼ阻害剤および抗ウイルス剤としてのピロン誘導体
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR19980703559A (ko) 1995-04-04 1998-11-05 그레이엄브레레톤 이미다조［1,2-ａ］피리딘 유도체
NZ504045A (en) 1997-11-19 2001-06-29 Kowa Co Pyridazine derivatives with inhibitory action against interleukin-1-beta production
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives

Also Published As

Publication number Publication date
EP1263751A1 (en) 2002-12-11
DE60103859T2 (de) 2005-07-21
DE60103859D1 (de) 2004-07-22
WO2001068633A1 (en) 2001-09-20
JP2003527389A (ja) 2003-09-16
CA2403149A1 (en) 2001-09-20
SK12832002A3 (sk) 2003-11-04
US7354936B2 (en) 2008-04-08
MXPA02009016A (es) 2004-10-15
EE200200528A (et) 2004-04-15
IL151598A0 (en) 2003-04-10
KR20030005221A (ko) 2003-01-17
NO20024393L (no) 2002-11-13
RU2002127728A (ru) 2004-03-20
EP1263751B1 (en) 2004-06-16
US20030232880A1 (en) 2003-12-18
NO20024393D0 (no) 2002-09-13
CN1429221A (zh) 2003-07-09
BR0109252A (pt) 2002-12-24
BG107101A (bg) 2003-07-31
HK1048117A1 (zh) 2003-03-21
CZ20023058A3 (cs) 2004-01-14
ATE269316T1 (de) 2004-07-15
AU2001254692A1 (en) 2001-09-24
HUP0301696A2 (hu) 2003-09-29
ES2223830T3 (es) 2005-03-01
PL358062A1 (en) 2004-08-09
NZ521187A (en) 2004-03-26
ZA200207184B (en) 2003-12-08
AR030410A1 (es) 2003-08-20

Similar Documents

Publication Publication Date Title
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
NO20054082L (no) Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
BR0009507A (pt) Derivados de ftalazina para o tratamento de doenças inflamatórias
EP1173484A4 (en) TREATMENT OF FIBROSIS BY ANTAGONISM BETWEEN IL-13 AND IL-13 RECEPTOR CHAINS
NO20073465L (no) Benzotiazol-derivater
NO990912L (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-agonister og bruken derav
ATE304533T1 (de) Tetrahydrochinolinderivate als muscarinische agonisten
NO20021035L (no) Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
PE20001067A1 (es) Derivados de 2-fenilpiran-4-ona
UY24499A1 (es) Nuevos derivados de 2-(3h)-oxazolona
RU98119076A (ru) Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2
RU2005131018A (ru) Производное бензофурана
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
PE20011333A1 (es) Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
ATE236134T1 (de) Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren
DK1000046T3 (da) Piperazinderivater, der er aktive på den nedre urinvejskanal
EE200100188A (et) Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
SE0004101D0 (sv) New use
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
DK0850062T3 (da) Anvendelse af halofuginon til fremstilling af et medikament til svækkelse af neovaskularisering og til behandling af maligne tumorer hos mennesker
BR0107405A (pt) Derivados de indol que atuam como antagonistas do receptor mcp-1
ES2123741T3 (es) Derivados de bencimidazol, su preparacion y uso.
NO20006065D0 (no) Cyanoiminokinoksalinderivater

Legal Events

Date Code Title Description
FD Application declared void or lapsed